Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

126.67 +2.82 (+2.28%)
Streaming Delayed Price Updated: 3:32 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
A Biotech Breakout Will Be Led By Small Caps ↗
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
News headline image
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
News headline image
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners ↗
Dozens of Top Ranked Magnet stocks breaking out 
Via Talk Markets
News headline image
The Door Is Open, Time For The Fed To Act ↗
With the CPI trending down and heading in the right direction, most economists are optimistic that the door is open for the Fed to lower rates. Economists, analysts, and investors are all waiting for... 
Via Talk Markets
Topics Economy
News headline image
Stocks Hit Pause As Economic Uncertainty Tempers The Rally ↗
Stocks have been on a red-hot rally, but they’ve hit the brakes right at technical resistance, just as the charts predicted. 
Via Talk Markets
News headline image
Bearish Shooting Star Shines ↗
Following signs of resistance in biotech ETF XBI on Friday, a shooting star forms. A bearish retracement may take hold soon.. 
Via Talk Markets
Topics ETFs
News headline image
Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally ↗
Weaker than expected PPI up only 0.1% ignite rally with decline in services. Rate cuts imminent for September. 
Via Talk Markets
News headline image
Healthcare Stocks Are Coming On Strong In July Led By Biotech ↗
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
News headline image
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. ↗
The Federal Reserve's fight against inflation may soon yield financial benefits. 
Via The Motley Fool
Topics Economy
News headline image
The Dow, The Russell, And The Biotech Sector Are Storming Higher ↗
The Dow Jones Industrials have come up 4.2% over the latest five-day, while the Russell 2000 index of U.S. small-caps is up nearly 11% - it’s having its best week in 24 years. 
Via Talk Markets
Topics Stocks
News headline image
AskSlim Market Week - Friday, July 12 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
Stocks Are Breaking Down Beneath The Surface ↗
Stocks and sectors are showing real signs of weakness despite the headline indexes going higher. 
Via Talk Markets
News headline image
Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
News headline image
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗
June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged. 
Via Benzinga
Topics ETFs
News headline image
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
News headline image
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React ↗
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
Via Benzinga
Topics Economy
News headline image
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO ↗
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services. 
Via Talk Markets
News headline image
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge ↗
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024. 
Via InvestorPlace
News headline image
American Express, Trade Desk And More: CNBC's 'Final Trades' ↗
American Express Company has "above market growth for below market multiple," Amy Raskin of Chevy Chase Trust said. 
Via Benzinga
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in June 2024 ↗
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate 
Via InvestorPlace
News headline image
Should I Be Worried? Stock Market (And Sentiment Results)… ↗
We are aggressively putting money to work in individual companies that are excessively undervalued relative to what we believe their normalized earnings power will look like as their recoveries... 
Via Talk Markets
News headline image
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. 
Via InvestorPlace
News headline image
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗
Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024. 
Via InvestorPlace
News headline image
For Biotech Stocks To Move Higher, This Must Move Lower ↗
While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure. 
Via Talk Markets
News headline image
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
Via Benzinga
News headline image
AskSlim Market Week - Friday, April 26 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition ↗
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now. 
Via InvestorPlace
News headline image
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
News headline image
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns ↗
Stocks initially rose on positive jobless claims report, but dropped later as Fed officials expressed doubts about interest rate cuts this year. 
Via Benzinga
Topics Economy
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.